ViaDerma Inc (VDRM)

[Avoid]

The company is also seeking to venture in the cannabis industry, which is set to reach $20 billion by 2020 thanks to the outcome of the November 8 vote to legalize the use of medical or recreational marijuana in several states. The company announced the Patent Pending use of its innovative transdermal system for the delivery of Calanoids and Tetrahydrocannabinol for the treatment of several diseases.

With that, the company has several potential revenue streams lined up and the commercialization of its products could lend tremendous upside to share prices. CBD is often used for the reduction of inflammation and for the treatment of several diseases, such as, nicotine addiction, fibromyalgia, Cohn’s disease, schizophrenia, migraine headaches, pain management for cancer and Multiple Sclerosis and the addition of transdermal delivery can spur immediate absorption into the bloodstream.

VDRM